Pleural and pulmonary involvement in systemic lupus erythematosus

Presse Medicale

Volumn 40, Issue 1 PART2, 2011, Pages

  Torre, Olga ^a   Harari, Sergio ^a  

^a San Giuseppe Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE; PNEUMOCOCCUS VACCINE; PREDNISONE; PROSTACYCLIN; TACROLIMUS; VASODILATOR AGENT;

ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTHRITIS; ATELECTASIS; DIAPHRAGM DISEASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA; HEART DISEASE; HEART FAILURE; HEMATOLOGIC DISEASE; HEMOPTYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; KIDNEY DISEASE; KIDNEY FAILURE; LUNG ALVEOLITIS; LUNG DISEASE; LUNG EMBOLISM; LUNG HEMORRHAGE; LUNG LAVAGE; LUNG PARENCHYMA; MOUTH ULCER; MUSCLE DISEASE; MYOPATHY; NEUROLOGIC DISEASE; ORGANIZING PNEUMONIA; PHOTOSENSITIVITY; PLASMAPHERESIS; PLEURA DISEASE; PLEURA EFFUSION; PLEURISY; PNEUMOCOCCAL INFECTION; PNEUMONIA; POLYSEROSITIS; PREVALENCE; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; PULMONARY VENO-OCCLUSIVE DISEASE; SHORT SURVEY; SURVIVAL RATE; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSTHORACIC BIOPSY; TREATMENT RESPONSE;

EID: 84866317676     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2010.11.004     Document Type: Short Survey

References (101)

1. Siegel M., Lee S.L. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 1973, 3:1-54.
2. Boddaert J., Huong D.L., Amoura Z., Wechsler B., Godeau P., Piette J.C., et al. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore) 2004, 83:348-359.
3. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
4. Vitali C., Bencivelli W., Isenberg D.A., Smolen J.S., Snaith M.L., Sciuto M., et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992, 10:527-539.
5. Crestani B. The respiratory system in connective tissue disorders. Allergy 2005, 60:715-734.
6. Kao A.H., Manzi S. How to manage patients with cardiopulmonary disease?. Best Pract Res Clin Rheumatol 2002, 16:211-227.
7. Bartholomew W.R., Shanahan T.C. Complement components and receptors: deficiencies and disease associations. ImmunolSeries 1990, 52:33-51.
8. Piliero P., Furie R. Functional asplenia in systemic lupus erythematosus. Semin Arthritis Rheum 1990, 20:185-189.
9. Hellman D.B., Petri M., Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: The role of opportunistic organisms. Medicine 1987, 66:341-348.
10. Cervera R., Khamashta M.A., Font J., Sebastiani G.D., Gil A., Lavilla P., et al. European Working Party on Systemic Lupus Erythematosus: Morbidity and mortality in systemic lupus erythematosus during a 10- year period. A comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore) 2003, 82:299-308.
11. Swigris J.J., Fischer A., Gilles J., Meehan R.T., Brown K.K. Pulmonary and Thrombotic Manifestations of Systemic Lupus Erythematosus. Chest 2008, 133:271-280.
12. Elkayam O., Paran D., Caspi D., Litinsky I., Yaron M., Charboneau D., et al. Immunogenicity and safety of pneumococcalvaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 2002, 34:147-153.
13. Ku A.S.W., Lee K.W., Wan K.L., Chan W.K.Y. Coexisting pneumocystis carinii and cytomegalovirus pneumonia in systemic lupus erythematosus. HK J Paediatr (new series) 1999, 4:101-103.
14. Murin S., Wiedemann H.P., Matthay R.A. Pulmonary manifestations of systemic lupus rythematosus. Clin Chest Med 1998, 19:641-665.
15. Nöel V., Lortholary O., Casassus P., Cohen P., Généreau T., André M.H., et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 2001, 60:1141-1144.
16. Bosch X., Guilabert A., Pallares L., Cervera R., Ramos-Casals M., Bové A., et al. Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 2006, 15:584-589.
17. Gladman D.D., Hussain F., Ibañez D., Urowitz M.B. The nature and outcome of infection in systemic lupus erythematosus. Lupus 2002, 11:234-239.
18. Chen H.S., Tsai W.P., Leu1 H.S., Ho H.H., Liou L.B. Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology 2007, 46:539-544.
19. Podrebarac T.A., Jovaisas A., Karsh J. Pneumocystis carinii pneumonia after discontinuation of hydroxychloroquine in 2 patients with systemic lupus erythematosus. J Rheumatol 1996, 23:199-200.
20. Wiedemann H.P., Matthay R.A. Pulmonary manifestations of systemic lupus erythematosus. J Thorac Imag 1992, 7:1-18.
21. Haupt H.M., Moore G.W., Hutchins G.M. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 1981, 71:791-798.
22. Colby T.V. Pulmonary pathology in patients with systemic autoimmune diseases. Clin Chest Med 1998, 19:587-612.
23. Zamora M.R., Warner M.L., Rubin Tuder, Schwarz M.I. Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome. Medicine 1997, 76:192-202.
24. Santos-Ocampo A.S., Mandell B.F., Fessler B.J. Alveolar hemorrhage in systemic lupus erythematosus. Presentation and management. Chest 2000, 118:1083-1090.
25. Badsha H., Teh C.L., Kong K.O., Lian T.Y., Chng H.H. Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 2003, 33:414-421.
26. Chang M.Y., Fang J.T., Chen Y.C., Huang C.C. Diffuse alveolar hemorrhage in systemic lupus erythematosus: a single center retrospective study in Taiwan. Renal Failure 2002, 24:791-802.
27. Cañas C., Tobón G., Granados M., Fernández L. Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus. Clin Rheumatol 2007, 26:1947-1949.
28. Koh W.H., Thumboo J., Boey M.L. Pulmonary hemorrhage in Oriental patients with systemic lupus erythematosus. Lupus 1997, 6:713-716.
29. Schwab E.P., Schumacher H.R., Freundlich B., Callegari P.E. Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 1993, 23:8-15.
30. Lee J.G., Joo K.W., Chung W.K., Jung Y.C., Zheung S.H., Yoon H.J., et al. Diffuse alveolar hemorrhage in lupus nephritis. Clin Nephrol 2000, 54:282-288.
31. Myers J.L., Katzenstein A.L. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986, 85:552-556.
32. Churg A., Franklin W., Chan K.L., Kopp E., Carringnton C.B. Pulmonary hemorrhage and immune-complex deposition in the lung. Arch Pathol Lab Med 1980, 104:388-391.
33. Eagen J.W., Memoli V.A., Roberts J.L., Matthew G.R., Schwartz M.M., Lewis E.J. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine 1978, 57:545-560.
34. Marino C.T., Pertschuk L.P. Pulmonary hemorrhage in systemic lupus erythematosus. Arch Intern Med 1981, 141:201-203.
35. Setoyama S., Fukumaru S., Takasaki T., Yoshida H., Kanzaki T. SLE with death from acute massive pulmonary hemorrhage caused by disseminated strongyloidiasis. Scan J Rheumatol 1997, 26:389-391.
36. Howe H.S., Boey M.L., Fong K.Y., Feng P.H. Pulmonary hemorrhage, pulmonary infarction, and the lupus anticoagulant. Ann Rheum Dis 1988, 47:869-872.
37. Travis W.D., Colby T.V., Lombard C., Carpenter A. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990, 14:1112-1125.
38. Hughson M.D., He Z., Henegar J., McMurray R. Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus. Immune complex small vascular injury with apoptosis. Arch Pathol Lab Med 2001, 125:475-483.
39. Falk R.J., Hogan S., Carey T.S., Jennette J.C. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 1990, 113:656-663.
40. Crausman R.S., Achenbach G.A., Pluss W.T., O'Brien R.F., Jennings C.A. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J Rheumatol 1995, 22:554-556.
41. Schwarz M.I., Sutarik J.M., Nick J.A., Leff J.A., Emlen J.W., Tuder R.M. Pulmonary capillaritis and diffuse alveolar hemorrhage. A primary manifestation of polymyositis. Am J Respir Crit Care Med 1995, 151:2037-2040.
42. Kim J.S., Lee K.S., Koh E.M., Kim S.Y., Chung M.P., Han J. Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings. J Comput Assist Tomogr 2000, 24:9-18.
43. Ewan P.W., Jones H.A., Rhodes C.G., Hughes J.M. Detection of intrapulmonary hemorrhage with carbon monoxide uptake. Application in Goodpasture's syndrome. N Engl J Med 1976, 295:1391-1396.
44. Raj R., Murin S., Matthay R.A., Wiedemann H.P. Systemic lupus erythematosus in the intensive care unit. Crit Care Clin 2002, 18:781-803.
45. Hoshi K., Matsuda M., Ishikawa M., Mitsuhashi S., Gono T., Hashimoto T., et al. Successful treatment of fulminant pulmonary hemorrhage associated with systemic lupus erythematosus. Clin Rheumatol 2004, 23:252-255.
46. Cheema G.S., Quismorio F.P. Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med 2000, 6:424-429.
47. Quismorio F.P. Pulmonary manifestations of systemic lupus erythematosus. Dubois' lupus erythematosus 1997, 673-692. Williams & Wilkins. Fifth Edn. D.J. Wallace, B.M. Hahn (Eds.).
48. Specks U. Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol 2001, 13:12-17.
49. Jacobson S., Petersen J., Ullman S., Junker P., Voss A., Rasmussen J.M., et al. A multicenter study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analysis of clinical subsets. Clin Rheumatol 1998, 17:468-477.
50. Jacobson S., Petersen J., Ullman S., Junker P., Voss A., Rasmussen J.M., et al. A multicenter study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 1998, 17:478-484.
51. Fenlon H.M., Doran M., Sant S.M., Breatnach E. High resolution CT in systemic lupus erythematosus. AJR Am J Roentgenol 1996, 166:301-307.
52. Bankier A.A., Kiener H.P., Wiesmayr M.N., Fleischmann D., Kontrus M., Herold C.J., et al. Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology 1995, 196:835-840.
53. Sant S.M., Doran M., Fenelon H.M., Breatnach E.S. Pleuropulmonary abnormalities in patients with systemic lupus erythematosus: assessment with high resolution computed tomography, chest radiography and pulmonary function tests. Clin Exp Rheumatol 1997, 15:507-513.
54. Boulware D.W., Hedgepeth M.T. Lupus pneumonitis and anti-SSA (Ro) antibodies. J Rheumatol 1989, 16:479-481.
55. Eisenberg H., Dubois E.L., Sherwin R.P., Balchum O.J. Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 1973, 79:37-45.
56. Weinrib L., Sharma O.P., Quismorio F.P. A long term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 1990, 20:48-56.
57. Devaraj A., Wells A.U., Hansell D.M. Computed tomographic imaging in connective tissue diseases. Semin Respir Crit Care Med 2007, 28:297-389.
58. Tansey D., Wells A.U., Colby T.V., Ip S., Nikolakoupolou A., du Bois R.M., et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004, 44:585-596.
59. Filipek M.S., Thompson M.E., Wang P.L., Gosselin M.V., Primack L.S. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus: radiographic and high-resolution CT findings. J Thorac Imaging 2004, 19:200-203.
60. Yood R.A., Steigman D.M., Gill L.R. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus. Lupus 1995, 4:161-163.
61. Yum H.K., Kim E.S., Ok K.S., Lee H.K., Choi S.J. Lymphocytic interstitial pneumonitis associated with Epstein-Barr virus in systemic lupus erythematosus and Sjögren's Syndrome. Complete remission with corticosteriod and cyclophosphamide. Korean J Intern Med 2002, 17:198-203.
62. Min J.K., Hong Y.S., Park S.H., et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus. J Rheumatol 1997, 24:2254-2257.
63. Otsuka F., Amano T., Hashimoto N., Park J.H., Lee S.H., Lee Y.S., et al. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus with antiphospholipid antibody. Intern Med 1996, 35:341-344.
64. Gammon R.B., Bridges T.A., al-Nezir H., Alexander C.B., Kennedy J.I. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest 1992, 102:1171-1174.
65. Renzoni E., Rottoli P., Coviello G., Perari M.G., Galeazzi M., Vagliasindi M., et al. Clinical, laboratory and radiological findings in pulmonary fibrosis with and without connective tissue disease. Clin Rheum 1997, 16:570-577.
66. D'Cruz D., Kamastha M., Hughes G. Pulmonary manifestations of systemic lupus erythematosus in Dubois lupus erythematosis 2002, 666-683. Lippincott Williams and Wilkins. 6th ed.
67. Manganelli P., Salaffi F., Pesci A. Clinical and subclinical alveolitis in connective tissue diseases assessed by bronchoalveolar lavage. Semin Arthritis Rheum 1997, 26:740-754.
68. Wallaert B., Hatron P.Y., Grosbois J.M., Tonnel A.B., Devulder B., Voisin C. Subclinical pulmonary involvement in collagen vascular diseases assessed by bronchoalveolar lavage: relationship between alveolitis and subsequent changes in lung function. Am Rev Respir Dis 1986, 133:574-580.
69. Somers E., Magder L.S., Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2002, 29:2531-2536.
70. Ruiz-Irastorza G., Egurbide M.V., Ugalde J., Aguirre C. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med 2004, 164:77-82.
71. Wahl D.G., Guillemin F., de Maistre E., et al. Risk for venous thrombosis related to antiphospholipid antibodies in sistemi lupus erythematosus: a meta-analysis. Lupus 1997, 6:467-473.
72. Asherson R.A., Cervera R., Shepshelovich D., Perret C., Lecompte T., Thibaut G. Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis?. J Rheumatol 2006, 33:1038-1044.
73. Asherson R.A., Cervera R., Piette J.C., Shoenfeld Y., Espinosa G., Petri M.A., et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001, 80:355-377.
74. Bucciarelli S., Espinosa G., Asherson R.A., Cervera R., Claver G., Gómez-Puerta J.A., et al. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis 2006, 65:81-86.
75. Lawrence E.C. Systemic Lupus Erythematosus and The Lung. System Lupus Erythematosus 2004, 961-974. Elsevier Academic Press. Fourth Edition. R.G. Lahita (Ed.).
76. Simonneau G., Galie N., Rubin L.J., Langleben D., Seeger W., Domenighetti G., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004, 43:5S-12S.
77. Hachulla E., Gressin V., Guillevin L., Carpentier P., Diot E., Sibilia J., et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005, 52:3792-3800.
78. Mukerjee D., St George D., Coleiro B., Knight C., Denton C.P., Davar J., et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003, 62:1088-1093.
79. Perez H.D., Kramer N. Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature. Semin Arthritis Rheum 1981, 11:177-181.
80. Badui E., Garcia-Rubi D., Robles E., Jimenez J., Juan L., Deleze M., et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985, 36:431-441.
81. Simonson J.S., Schiller N.B., Petri M., Hellmann D.B. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989, 16:918-925.
82. Winslow T.M., Ossipov M.A., Fazio G.P., Simonson J.S., Redberg R.F., Schiller N.B. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 1995, 129:510-515.
83. Robbins I.M., Gaine S.P., Schilz R., Tapson V.F., Rubin L.J., Loyd J.E. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Chest 2000, 117:14-18.
84. Kishida Y., Kanai Y., Kuramochi S., Hosoda Y. Pulmonary venoocclusive disease in a patient with systemic lupus erythematosus. J Rheumatol 1993, 20:2161-2162.
85. Li E.K., Tam L.S. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients. J Rheumatol 1999, 26:1923-1929.
86. Chung S.M., Lee C.K., Lee E.Y., Yoo B., Lee S.D., Moon H.B. Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol 2006, 25:866-872.
87. Humbert M., Sanchez O., Fartoukh M., Jagot J.L., Sitbon O., Simonneau G. Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin). Chest 1998, 114:80S-82S.
88. Tanaka E., Harigai M., Tanaka M., Kawaguchi Y., Hara M., Kamatani N. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol 2002, 29:282-287.
89. Sanchez O., Sitbon O., JaRs X., Simonneau G., Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 2006, 130:182-189.
90. Jais X., Launay D., Yaici A., Le Pavec J., Tchérakian C., Sitbon O., et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum 2008, 58:521-531.
91. Warrington K.J., Moder K.G., Brutinel W.M. The shrinking lungs in systemic lupus erythematosus. Mayo Clin Proc 2000, 75:467-472.
92. Muñoz-Rodriguez F.J., Front J., Badia J.R., Miret C., Barberà J.A., Cervera R., et al. Shrinking lung syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy. Lupus 1997, 6:412-414.
93. Wilcox P., Stein H., Clarke S., Pare P., Pardy R. Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus. Chest 1988, 93:352-358.
94. Laroche C.M., Mulvey D.A., Hawkins P.N., Walport M.J., Strickland B., Moxham J., et al. Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med 1989, 71:429-439.
95. Hardy K., Herry I., Attali V., Cadranel J., Similowski T. Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 2001, 119:1274-1277.
96. Karim M.Y., Miranda L.C., Tench C.M., Gordon P.A., D'Cruz D.P., Khamashta M.A., et al. Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. Semin Arthritis Rheum 2002, 31:289-298.
97. Oud K.T., Ten Berge R.J., Jonkers R.E., Bresser P. The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy. Lupus 2005, 14:959-963.
98. Walz-Leblanc B.A., Urowitz M.B., Gladman D.D., Hanly P.J. The shrinking lungs syndrome in systemic lupus erythematosus-improvement with corticosteroid therapy. J Rheumatol 1992, 19:1970-1972.
99. Argov Z. Drug-induced myopathies. Curr Opin Neurol 2000, 13:541-545.
100. Casado E., Gratacós J., Tolosa C., Martínez J.M., Ojanguren I., Ariza A., et al. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis 2006, 65:385-390.
101. Cutolo M., Otsa K. Review: vitamin D, immunity and lupus. Lupus 2008, 17:6-10.